Sentage Holdings Inc.

We are a growing financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China. Leveraging our deep understanding of our client base, strategic partner relationships, and proprietary valuation models and technologies, we are committed to working with our […]

July 9, 2021 Read More

Digital World Acquisition Corp.

We intend to focus our search on middle-market emerging growth technology-focused companies in the Americas, in the SaaS and Technology or FinTech and Financial Services sectors. Our management team is led by Patrick Orlando, our chairman and CEO, who has served many executive roles in Finance over a 25-year career. He has been involved in special […]

Read More

SERA PROGNOSTICS, INC.

We are a women’s health diagnostic company focused on improving pregnancy outcomes. Our first commercial product, the PreTRM test, is the only broadly validated commercially available blood-based biomarker test to accurately predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, […]

July 8, 2021 Read More

Sight Sciences, Inc.

Our mission is to transform ophthalmology and optometry through the development and commercialization of proprietary devices that target the underlying causes of the world’s most prevalent eye diseases.  Our currently marketed products, the OMNI Surgical System, or OMNI, and the TearCare System, or TearCare, target two of the world’s most prevalent and underserved eye diseases, […]

Read More

Bridge Investment Group Holdings Inc.

We are a leading vertically integrated real estate investment manager, diversified across specialized asset classes, with approximately $26 billion of AUM (assets under management) as of March 31, 2021. Our ability to scale our specialized and operationally driven investment approach across multiple attractive sectors within real estate equity and debt, in a way that creates sustainable […]

Read More

F45 Training Holdings Inc.

We are F45 Training, one of the fastest-growing fitness franchisors in the United States based on number of franchises sold in the United States, focused on creating a leading global fitness training and lifestyle brand. We offer consumers functional 45-minute workouts that are effective, fun and community-driven. Our workouts combine elements of high-intensity interval, circuit and functional […]

Read More

Good Works II Acquisition

We intend to initially focus our search on identifying a prospective target business experiencing very high growth and with an enterprise value of $1 billion or more. (Note:  This is the second SPAC or blank-check company established under the Good Works name.)  Our name, Good Works, embodies our complementary objectives of (1) investing in a high-quality […]

Read More

Galata Acquisition Corp.

We intend to focus on technology-enabled financial services businesses in emerging markets. Segments we might explore include, but are not limited to, insurance, reinsurance and insurance services, asset management, retail or investment banking, and merchant acquisition and payment processing. (Incorporated in the Cayman Islands) We were co-founded by an affiliated fund of Callaway Capital Management, […]

Read More

Acropolis Infrastructure Acquisition Corp.

We intend to focus our search for a business combination target in infrastructure, infrastructure services and related sectors in North America. Our sponsor is an affiliate of Apollo Global Management. Apollo is a high-growth, global alternative asset manager with approximately $461 billion of assets under management as of March 31, 2021. Geoffrey Strong serves as our CEO and […]

Read More

Stevanato Group S.p.A.

We are a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. We deliver an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Our core capabilities in scientific […]

Read More
Page 167 of 301« First...102030...165166167168169...180190200...Last »